Cyclacel's Fourth Round Gets $39M For Cell Cycle Inhibitors Feb. 4, 2004 By Nuala Moran LONDON - Cyclacel Ltd. raised £21.3 million (US$39 million) in an oversubscribed fourth round of private funding, bringing its total private equity raised to date to $123 million. (BioWorld International)Read More
